Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia's Amplia Therapeutics rises as US FDA fast-tracks cancer drug

** Shares of Amplia Therapeutics  ATX.AX  rise as much as
36.7% to A$0.135, set for best day since Aug 6, if gains hold   
 
    ** The drug developer says the United States Food and Drug
Administration (FDA) has granted fast-track designation to co's
drug narmafotinib 
    ** Drug used to treat advanced pancreatic cancer
    ** Stock hits highest since Sept 2    
    ** Amplia stock up 67.2% YTD, as of 1255 GMT

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news